What is CRISM Therapeutics Corporation (CRTX.L)?

CRISM Therapeutics Corporation (CRTX.L) is a stock in the Healthcare sector, Biotechnology industry. View full analysis on Stocks360.

CRISM Therapeutics Corporation (CRTX.L)

Stock analysis · LSE · Healthcare · Biotechnology

Market Cap

N/A

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

0.59

Day Range

N/A

52-wk Range

N/A

Avg Volume

N/A

Volume

N/A

CRISM Therapeutics Corporation (CRTX.L) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About CRISM Therapeutics Corporation

CRISM Therapeutics Corporation is dedicated to developing innovative drug delivery systems that enhance the effectiveness of cancer medications targeting solid tumors. Their primary offering, ChemoSeed, is designed for direct insertion into a tumor or the surgical site post-tumor removal, ensuring that therapeutic concentrations of chemotherapy agents are precisely localized to the cancerous tissue. This technology finds particular application in treating gliomas, a form of brain tumor. The company was established in 2016 and is headquartered in Road Town, British Virgin Islands.